AdAlta Limited (ASX:1AD)
Australia · Delayed Price · Currency is AUD 0.0030
0.00 (0.00%)
Jun 18, 2026, 1:47 PM AEST
AdAlta Market Cap
AdAlta has a market cap or net worth of 7.97 million as of June 18, 2026. Its market cap has increased by 106.49% in one year.
Market Cap
7.97M
Enterprise Value
6.38M
Revenue
608.07K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.00
Market Cap Chart
Since August 22, 2016, AdAlta's market cap has decreased from 28.00M to 7.97M, a decrease of -71.54%. That is a compound annual growth rate of -12.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 7.97M | 15.72% |
| Dec 31, 2025 | 6.89M | -31.84% |
| Dec 30, 2024 | 10.10M | -19.94% |
| Dec 29, 2023 | 12.62M | -2.04% |
| Dec 29, 2022 | 12.88M | -45.79% |
| Dec 29, 2021 | 23.76M | -22.47% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Aug 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Argenica Therapeutics | 14.13M |
| Cambium Bio | 12.98M |
| Immuron | 9.80M |
| Invex Therapeutics | 9.77M |
| Vectus Biosystems | 9.22M |
| Acrux | 7.70M |
| Biotron | 6.75M |
| Bio-Gene Technology | 6.10M |